Application no. and date | 10835036.4 (espacenet) (Federated) (European Patent Register), 20101201 | Patent/reg. no. and date | DK/EP 2506881, 20240306 | Publication date | 20121010 | Priority no. and date | US 629404, 20091202, US 266356 P, 20091203, US 292656 P, 20100106, US 322997 P, 20100412, US 323952 P, 20100414 | EP pub. no. and date |
EP 2506881 20121010 | Effective date | | Applicant/owner | Immunomedics, Inc., c/o Gilead Sciences, Inc. 333 Lakeside Drive Foster City CA 94404, US | Applicant ref. no. | | Inventor | GOLDENBERG, David M., 300 American Road
Morris Plains New Jersey 07950, US, GOVINDAN, Serengulam V., 300 American Road
Morris Plains New Jersey 07950, US | Representative | | Opponent | | IPC Class | A61K 31/7068 (2006.01) , A61K 39/00 (2006.01) , A61K 41/00 (2020.01) , A61K 47/68 (2017.01) , A61K 51/00 (2006.01) , A61K 51/10 (2006.01) , A61P 35/00 (2006.01) | Title | COMBINING RADIOIMMUNOTHERAPY AND ANTIBODY-DRUG CONJUGATES FOR IMPROVED CANCER THERAPY | Int. application no. | US2010058519 | Int. publication no. | WO2011068845 | Related patent (certificate) | | Status | Enhedspatent registreret | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|